“As private equity firms make it rain on healthcare companies, some in the industry worry that patients will pay the price.”
So begins a recent Modern Healthcare article on private equity’s entry into areas including Ophthalmology, physician staffing services, and Dermatology. AMA President Dr. Barbara McAneny is quoted as calling this trend “just another wave” in a broader tide of consolidation. But to read most of the press around PE in Dermatology is to imagine that we’re handing over our specialty to Bernie Madoff. In this view, any Dermatologist practicing in a PE-backed group is merely an instrument of profit-seeking villainy; our “conflict of interest” means we no longer see our patients as people, but as dollar signs.
I joined Dermatology Associates of Wisconsin, the group practice that became Forefront, because of its values, its culture, and its focus on patient care. None of those have changed with the backing of PE—even while our access to resources and support certainly has. Forefront’s doctors enjoy PE backing but have retained decision-making power over every inch of the group’s operations. When asked by an interviewer how aware he was of PE involvement in Forefront, one Dermatologist answered, “It’s invisible to me honestly. I have almost no awareness of it. To me, Forefront is the doctors, it’s the [central support] people who are there to help me…” The invisibility of PE plus the utility of our shared central services and support staff is, to our minds, the ideal configuration. PE is our bank, but our physicians are our backbone.